Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS).

Autores de IIS La Fe

• Francisco Orbis Castellanos

  Autor

Participantes ajenos a IIS La Fe

• Alvarez Alvarez, Rosa
• Manzano, Aranzazu
• Agra Pujol, Carolina
• Artigas Raventos, Vicente
• Correa, Raquel
• Cruz Jurado, Josefina
• Fernandez, Juan Angel
• Garcia del Muro, Xavier
• Gonzalez, Jose Antonio
• Hindi, Nadia
• Lozano Lominchar, Pablo
• Martinez-Trufero, Javier
• Mendez, Ramiro
• Munoz, Mercedes
• Munoz Casares, Cristobal
• Orellana Fernandez, Ruth
• Paniagua Gonzalez, Miguel
• Redondo, Andres
• Valverde Morales, Claudia
• Asencio, Jose Manuel

Grupos

• Hepatología, Cirugia Hepatobiliopancreática y Trasplantes

Abstract

Soft tissue sarcomas (STS) are an uncommon and biologically heterogeneous group of tumors arising from mesenchymal cells. The incidence is estimated at five cases per 100,000 people per year. Retroperitoneal sarcomas (RPS) account for 10-15% of all STS, and their management depends on their anatomical characteristics and histotype. Due to their very low incidence, it is recommended that RPS be treated in reference centers and evaluated by an experienced multidisciplinary team (MDT). In Spain, the Spanish Group for Research in Sarcomas (GEIS) brings together experts from various specialties to promote research on sarcomas and improve treatment results. This paper summarizes the GEIS recommendations for the diagnosis, treatment, and follow-up of patients with RPS.

Keywords

• multidisciplinary board; reference centers; retroperitoneal sarcoma; retroperitoneum; soft tissue sarcoma